These reagents are required due to an increase in testing volume of public health/infectious disease testing. Our lab will temporarily be supporting/taking on the workload of another MTF until they…
Ended Awarded
- Contract number
- HT009025FG0830107
- Awardee
-
Hologic, Inc. UEI WHWJBKU5SX73
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $11,525
Award facts
- Contract value 100% obligated
- $11,525.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded Hologic, Inc. a $11,525 firm fixed-price BPA call on August 2, 2025, for the provision of diagnostic reagents to support increased public health and infectious disease testing volume. The work will be performed in Marlborough, Massachusetts, with completion scheduled for September 30, 2025. This contract represents a call against an existing Blanket Purchase Agreement, which provides the Defense Health Agency with streamlined access to Hologic's molecular diagnostic consumables and related products. The award carries no set-aside designation, reflecting Hologic's competitive standing as a prime contractor in the federal medical technology marketplace.
The reagents are required to temporarily augment laboratory capacity while another military treatment facility brings its analyzers into operational status. Hologic, a leading medical technology provider specializing in diagnostics and women's health solutions, maintains an established relationship with the Department of Defense and other federal health agencies through multiple contract vehicles. The company's comprehensive federal portfolio includes diagnostic platforms, mammography equipment, and associated consumables that support military and veteran healthcare infrastructure. This task order underscores the Defense Health Agency's reliance on commercial diagnostic capabilities to maintain testing throughput during periods of elevated demand or infrastructure transitions.
Description
These reagents are required due to an increase in testing volume of public health/infectious disease testing. Our lab will temporarily be supporting/taking on the workload of another MTF until they get their analyzers up and running.
Quick answers
Who was awarded contract HT009025FG0830107?
HT009025FG0830107 was awarded to Hologic, Inc. by Defense Health Agency (Department of Defense) on August 2, 2025.
How much is contract HT009025FG0830107 worth?
The government has obligated $11,525 on HT009025FG0830107.
Is contract HT009025FG0830107 an order under another contract?
Yes. HT009025FG0830107 is a BPA call under FA301624A0021, a blanket purchase agreement.
Was contract HT009025FG0830107 competed?
The extent of competition for HT009025FG0830107 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award